Enliven Therapeutics COO Helen Louise buys 40k shares at $2.48, sells at $35.1 on 2026-03-25.

Enliven Therapeutics, Inc., a publicly traded company, has announced that Collins Helen Louise, the company's Chief Medical Officer, has recently made a transaction involving the purchase and sale of a significant number of shares. On March 25, 2026, Collins Helen Louise acquired 40,000 shares at a price of $2.48 per share. Later that same day, she sold an equal number of shares at a price of $35.1 per share.